Form 4: OrthoPediatrics COO/CFO Disgorges Short-Swing Profit

OrthoPediatrics' COO and CFO, Fred Hite, purchased 5,076 shares but disgorged $27,664.20 due to a short-swing profit violation.

Summary

• Fred Hite, COO and CFO of OrthoPediatrics Corp. (KIDS) and a Director, purchased 5,076 shares of common stock on August 21, 2025, at a price of $19.41 per share.
• This purchase was made pursuant to a Rule 10b5-1(c) plan.
• Following this transaction, Mr. Hite beneficially owns 213,065 shares, which includes 150,360 restricted stock awards.
• Mr. Hite disgorged $27,664.20 to OrthoPediatrics Corp. because this purchase was matchable under Section 16(b) of the Exchange Act with a previous sale, representing the full amount of profit realized in connection with the short-swing transaction.

Sentiment

Score: 4

Explanation: While the insider purchase shows some confidence, the mandatory disgorgement due to a short-swing profit violation is a negative compliance event, slightly outweighing the positive signal of the purchase itself.

Positives

• The COO and CFO, Fred Hite, purchased 5,076 shares of common stock, indicating management's belief in the company's value.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, suggesting a pre-planned and structured approach to share acquisition.
• The disgorgement of profit demonstrates compliance with Section 16(b) regulations, even after a violation occurred.

Negatives

• Fred Hite was involved in a short-swing profit violation under Section 16(b) of the Exchange Act, requiring him to disgorge $27,664.20. This indicates a past compliance oversight.

Risks

• Reputational risk for the executive and potentially the company due to the Section 16(b) short-swing profit violation.
• Potential for increased scrutiny from investors regarding the company's internal controls and compliance procedures related to insider trading.

Future Outlook

The filing does not provide explicit forward-looking statements or guidance beyond the planned nature of the stock purchase under a Rule 10b5-1(c) plan.

Industry Context

This Form 4 filing is specific to an insider transaction and a compliance matter for OrthoPediatrics Corp. It does not directly relate to broader industry trends or competitive landscape, other than highlighting the importance of strict adherence to SEC regulations for all public company insiders.

Comparison to Industry Standards

• This filing details an insider transaction and a Section 16(b) violation, which is a compliance matter rather than a performance metric. Therefore, direct comparisons to industry-standard operational or financial results of comparable companies or projects are not applicable.
• The disgorgement of profit is a standard remedy for such violations across all public companies.

Corporate Governance

Legal Proceedings

• The filing describes a Section 16(b) short-swing profit violation, which is a regulatory compliance issue requiring disgorgement, rather than a formal legal proceeding or lawsuit.

Related Party Transactions

• The transaction involves an officer and director of the company, Fred Hite, which is a related party transaction. The disgorgement of profit is a resolution for a specific type of related party transaction (insider trading) under Section 16(b).

Stakeholder Impact

• Shareholders: May view the insider purchase as a positive signal of confidence, but the Section 16(b) violation could raise concerns about corporate governance and compliance. The disgorged profit benefits the company.
• Management: The COO and CFO faced a compliance issue, which could impact his reputation.
• Regulatory Authorities: The filing demonstrates the company's and insider's compliance with reporting and corrective actions for Section 16(b) violations.

Next Steps

• The filing does not explicitly mention any future actions, events, or milestones beyond the reported transaction.

Key Dates

Recommendation

The insider purchase by a key executive (COO and CFO) at $19.41 per share could be seen as a positive signal of confidence in the company's future. However, this positive is significantly tempered by the mandatory disgorgement of $27,664.20 due to a short-swing profit violation under Section 16(b). While the disgorgement itself shows compliance, the occurrence of the violation raises questions about internal controls and adherence to insider trading rules, which can be a red flag for investors. Given the mixed signals – insider buying offset by a compliance breach – a 'hold' recommendation is appropriate. Investors should monitor future insider transactions and any further corporate governance disclosures.

Keywords

OrthoPediatrics, KIDS, Fred Hite, Insider Trading, Form 4, SEC Filing, Short-Swing Profit, Section 16(b), Stock Purchase, COO, CFO, Corporate Governance, Rule 10b5-1